Keyphrases
Testicular Cancer
64%
Testicular Cancer Survivors
43%
Germ Cell Tumor
33%
National Cohort Study
26%
Bleomycin
24%
Prognostic Factors
20%
Cancer Patients
20%
Clinical Stage I
19%
Testicular Germ Cell Tumor
17%
Testosterone Replacement Therapy
17%
Cisplatin
15%
Etoposide
15%
Quality of Life
15%
Leydig Cells
13%
Confidence Interval
13%
Cancer Database
12%
Chemotherapy
12%
Risk Factors
11%
Radiotherapy
11%
Hazard Ratio
11%
Stage I Seminoma
10%
Placebo
10%
Orchiectomy
10%
Luteinizing Hormone
9%
Nonseminoma
9%
Leydig Cell Dysfunction
9%
Seminoma
9%
Post-chemotherapy
9%
Sexual Behavior
9%
Etoposide-cisplatin
9%
Testicular Seminoma
8%
Late Effects
8%
Relapse Risk
8%
Testosterone
8%
Overall Survival
8%
Glomerular Filtration Rate
7%
Non-seminoma
7%
Metabolic Syndrome
6%
Population-based Study
6%
Albert Einstein
5%
Randomized Double-blind Trial
5%
Cisplatin-based Chemotherapy
5%
Egfr
5%
Interleukin-17 (IL-17)
5%
Survivors
5%
Tumor Size
5%
Serum Levels
5%
Denmark
5%
Clinical Data
5%
Late Relapse
5%
Medicine and Dentistry
Testis Cancer
100%
Germ Cell Cancer
36%
Seminoma
34%
Cisplatin
24%
Cohort Analysis
23%
Interstitial Cell
23%
Clinical Stage
21%
Bleomycin
21%
Etoposide
21%
Prognostic Factor
20%
Androgen Therapy
18%
Substitution Therapy
16%
Neoplasm
16%
Quality of Life
14%
Orchiectomy
12%
Malignant Neoplasm
12%
Placebo
10%
Radiation Therapy
9%
Germinoma
9%
Luteinizing Hormone
9%
Recurrent Disease
9%
Overall Survival
9%
Hazard Ratio
7%
Contralateral
7%
Metabolic Syndrome
7%
Proportional Hazards Model
6%
Glomerular Filtration Rate
6%
Disease
6%
Systematic Review
5%
Testes
5%
Chorionic Gonadotropin
5%
Adjuvant Therapy
5%
DNA Template
5%
Prevalence
5%
